cancer clinical trials in kansas city, KS
|
University of Kansas Medical Center
Kansas City, Kansas 66160-7353 Myelodysplastic Syndromes, MDS, RAEB, Chronic Myelomonocytic Leukemia
|
|
University of Kansas Medical Center
Kansas City, Kansas 66160-7353 Breast Cancer
|
|
University of Kansas Medical Center
Kansas City, Kansas 66160-7353 Breast Cancer
|
|
University of Kansas Medical Center
Trial Locations University of Kansas Medical Center Kansas City Cancer Center-West Adenocarcinoma of the Gastroesophageal Junction, Adenocarcinoma of the Stomach, Recurrent Esophageal Cancer, Recurrent Gastric Cancer
|
|
University of Kansas Medical Center
Kansas City, Kansas 66160-7353 Breast Cancer
|
|
University of Kansas Medical Centner
Kansas City, Kansas 66160 Metastatic Breast Cancer
|
|
Kansas University Cancer Center
Kansas City, Kansas 66160 Acute Myelogenous Leukemia
|
|
University of Kansas Medical Center
Kansas City, Kansas 66160-7353 Prostatic Neoplasms
|
|
University of Kansas Medical Center
Kansas City, Kansas 66160-7353 GVHD, Adult Acute Myeloid Leukemia, Adult Acute Lymphoid Leukemia, Myelodysplastic Syndrome
|
|
University of Kansas Cancer Center Univ of KS
Kansas City, Kansas 66160 Non-small Cell Lung Cancer
|
|
Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
Kansas City, Kansas 66160-7353 Head and Neck Cancer, Precancerous Condition
|
|
University of Kansas Cancer Center
Kansas City, Kansas 66160 Colorectal Cancer
|
|
University of Kansas Cancer Center
Kansas City, Kansas 66160 Advanced Prostate Cancer, Prostatic Neoplasms
|
|
Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
Trial Locations Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center Kansas City Cancer Centers - West Prostate Cancer
|
|
University Of Kansas
Kansas City, Kansas 66160 Leukemia, Myelocytic, Acute
|
|
Kansas City, Kansas 66160 Advanced Liposarcoma or Leiomyosarcoma
|
|
University of Kansas Medical Center
Kansas City, Kansas 66160-7353 Breast Cancer
|
|
University of Kansas Medical Center
Trial Locations University of Kansas Medical Center Kansas City Cancer Center-West Colorectal Neoplasms
|
|
University of Kansas Cancer Center
Kansas City, Kansas 66160 Urothelial Carcinoma
|
|
University of Kansas Medical Center
Kansas City, Kansas 66160-7353 Renal Cell Carcinoma
|
|
Kansas City, Kansas 66160 Breast Cancer
|
|
University of Kansas Cancer Center
Kansas City, Kansas 66160 Metastatic Pancreatic Adenocarcinoma
|
|
Kansas City, Kansas 66160 Pain, Advanced Cancer
|
|
University of Kansas Medical Center
Kansas City, Kansas 66160-7353 Pancreatic Cancer
|
|
Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
Kansas City, Kansas 66160-7353 Prostate Cancer
|
|
Kansas City, Kansas 66160 Colorectal Cancer
|
|
Kansas City, Kansas 66160 Lambert Eaton Myasthenic Syndrome
|
|
University of Kansas Cancer Center Univ KS
Kansas City, Kansas 66160 Solid Tumors and Advanced Endometrial Cancer, Endometrial Cancer, Second-line Treatment, VEGF
|
|
University of Kansas Medical Center
Kansas City, Kansas 66160-7353 Breast Cancer
|
|
Kansas City, Kansas 66160 Pancreatic Cancer
|
|
Kansas City, Kansas 66160 Metastatic Non-Small Cell Lung Cancer
|
|
The University of Kansas Medical Center
Kansas City, Kansas 66160 Polycystic Ovarian Syndrome
|
|
Investigational Site Number 840010
Kansas City, Kansas 66160-7321 Lymphoma
|
|
The University of Kansas Medical Center
Kansas City, Kansas 66160 Ovarian Autotransplantation Using Cryopreserved Ovarian Tissue in Women Treated for Cancer
|
|
The University of Kansas Medical Center
Kansas City, Kansas 66160 Infertility, Breast Cancer
|
|
Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
Kansas City, Kansas 66160-7353 Cervical Cancer, Chemotherapeutic Agent Toxicity, Cognitive/Functional Effects, Psychosocial Effects of Cancer and Its Treatment, Radiation Toxicity, Sexuality and Reproductive Issues
|
|
University of Kansas Cancer Center
Kansas City, Kansas 66160 Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma, Leukemia, Prolymphocytic
|
|
Pfizer Investigational Site
Kansas City, Kansas 66112 Endometrial Neoplasms
|
|
University of Kansas Medical Center
Kansas City, Kansas 66160-7353 Breast Cancer
|
|
Kansas City, Kansas 66160 Breast Cancer
|
|
University of Kansas Medical Center
Kansas City, Kansas 66160-7353 Breast Cancer, Obesity
|
|
University of Kansas Medical Center
Kansas City, Kansas 66160-7353 Acute Myeloblastic Leukemia
|
|
Pfizer Investigational Site
Kansas City, Kansas 66112 Non Small Cell Lung Cancer (NSCLC)
|
|
University of Kansas Medical Center
Kansas City, Kansas 66160-7353 Relapsed Peripheral T-Cell Lymphoma, Refractory Peripheral T-Cell Lymphoma
|
|
Kansas City, Kansas 66160 High-risk Smoldering Multiple Myeloma
|
|
Kansas City Cancer Center
Kansas City, Kansas 66112 Locally Recurrent Breast Cancer, Metastatic Breast Cancer
|
|
Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
Trial Locations Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center Kansas City Cancer Centers - West Adenocarcinoma of the Gastroesophageal Junction, Esophageal Cancer, Gastric Cancer
|
|
University of Kansas Cancer Center Univ Kansas
Kansas City, Kansas 66160 Advanced NET of GI Origin, Advanced NET of Lung Origin, Neuroendocrine Tumors
|
|
Kansas City, Kansas 66160 Colorectal Neoplasms
|
|
Pfizer Investigational Site
Kansas City, Kansas 66112 Acute Myeloid Leukemia
|
|
University of Kansas Medical Center
Trial Locations University of Kansas Medical Center Kansas City Cancer Center-West Breast Cancer
|
|
University of Kansas Cancer Center
Kansas City, Kansas 66160 Myelodysplastic Syndrome
|
|
University of Kansas Cancer Center Univ Kansas 2
Kansas City, Kansas 66160 Breast Cancer
|
|
University of Kansas Cancer Center
Kansas City, Kansas 66160 Advanced Renal Cell Carcinoma, Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma
|
|
University of Kansas Cancer Center Medical Center
Kansas City, Kansas 66160 Advanced Solid Tumors, Excluding Breast Cancer
|
